北海康成-B再涨超25% 6月初至今累涨近9倍 维拉苷酶β存在潜在重磅BD可能性

智通财经
Aug 08

北海康成-B(01228)再涨超25%,6月初至今累计涨幅接近900%。截至发稿,涨22.64%,报1.3港元,成交额1517.64万港元。消息面上,5月15日,国家药品监督管理局通过优先审评审批程序批准北海康成申报的注射用维拉苷酶β(商品名:戈芮宁)上市,适用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者的长期酶替代治疗。7月3日,时代财经从北海康成获悉,其戈谢病一类创新药戈芮宁开出首张处方,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10